| Dr Amy Nicole Zastrow, MD | |
|
406 Welch St, Silverton, OR 97381-1934 | |
| (503) 364-3787 | |
| Not Available |
| Full Name | Dr Amy Nicole Zastrow |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 406 Welch St, Silverton, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942219431 | NPI | - | NPPES |
| 500607543 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD29272 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Silverton Medical Center | Silverton, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Silverton Health | 8921901877 | 104 |
News Archive
A radically different approach to treating high blood pressure – using a minimally invasive procedure – is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA's initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab (Erbitux®) in first-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).
Pregnancy was not found to raise the risk of stroke in older women, according to a study from Columbia University Medical Center and NewYork-Presbyterian. In younger women, however, the risk of stroke was significantly higher for those who were pregnant.
Monash University researchers are developing checklists to help general practitioners and support workers recognise depression in people with an intellectual disability.
› Verified 5 days ago
| Entity Name | Silverton Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669424354 PECOS PAC ID: 8921901877 Enrollment ID: O20040129000172 |
News Archive
A radically different approach to treating high blood pressure – using a minimally invasive procedure – is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA's initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab (Erbitux®) in first-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).
Pregnancy was not found to raise the risk of stroke in older women, according to a study from Columbia University Medical Center and NewYork-Presbyterian. In younger women, however, the risk of stroke was significantly higher for those who were pregnant.
Monash University researchers are developing checklists to help general practitioners and support workers recognise depression in people with an intellectual disability.
› Verified 5 days ago
| Entity Name | Roseburg Women S Health Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134243249 PECOS PAC ID: 1355322843 Enrollment ID: O20040528001372 |
News Archive
A radically different approach to treating high blood pressure – using a minimally invasive procedure – is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA's initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab (Erbitux®) in first-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).
Pregnancy was not found to raise the risk of stroke in older women, according to a study from Columbia University Medical Center and NewYork-Presbyterian. In younger women, however, the risk of stroke was significantly higher for those who were pregnant.
Monash University researchers are developing checklists to help general practitioners and support workers recognise depression in people with an intellectual disability.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Nicole Zastrow, MD 1475 Mount Hood Ave, Woodburn, OR 97071-9066 Ph: (971) 983-5260 | Dr Amy Nicole Zastrow, MD 406 Welch St, Silverton, OR 97381-1934 Ph: (503) 364-3787 |
News Archive
A radically different approach to treating high blood pressure – using a minimally invasive procedure – is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA's initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab (Erbitux®) in first-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).
Pregnancy was not found to raise the risk of stroke in older women, according to a study from Columbia University Medical Center and NewYork-Presbyterian. In younger women, however, the risk of stroke was significantly higher for those who were pregnant.
Monash University researchers are developing checklists to help general practitioners and support workers recognise depression in people with an intellectual disability.
› Verified 5 days ago
John P Yang, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Glenn Ira Bernstein, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Brooke Denise Renard, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Dr. Mark Calvin Rowley, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 607 Welch Street, Silverton, OR 97381 Phone: 503-873-7920 Fax: 503-873-7340 | |
Denis Jon Dalisky, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Dr. Barbara Linn Keller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 |